Home/PRD Therapeutics/Kanji Hosoda

KH

Kanji Hosoda

President and CEO, Co-Founder

PRD Therapeutics

Therapeutic Areas

Metabolic Disease Cardiovascular

PRD Therapeutics Pipeline

Drug	Indication	Phase
PRD001	Homozygous Familial Hypercholesterolemia (HoFH)	Phase 1
PRD002	HoFH and MASH/MASLD	Discovery/Lead Optimization
PRD003	Lysosomal Acid Lipase Deficiency (LAL-D)	Discovery
PRD004	Dyslipidemia	Discovery

Leadership Team at PRD Therapeutics

Outside Director, Co-Founder, Professor, Ph.D.

Tetsuya Mishima

Outside Director, Ph.D.

Taira Kobayashi

Outside Director, Ph.D.

View full PRD Therapeutics profile